Company / strategic investorRegistered location :1228 PLAN-LES-OUATESGroup :ADDEX PHARMA SA

ADDEX THERAPEUTICS LTDDeclared Swiss shareholdings

ADDEX THERAPEUTICS LTD: 1 Swiss companies with a declared holding, including Addex Therapeutics Ltd. Latest filing: 03.11.2026.

Disclosure tracking · company alerts with Pro
Estimated value (CHF)
…
Swiss companies held
1
Largest position
32,56 %
Addex Therapeutics Ltd
12-month trend
Net builder
1 rate rises · 0 rate falls
Latest filing
03.11.2026
Active since 2012

Declared Swiss portfolio

Latest declared rate per company

Sector allocation

Share of companies held
How to read these figures?

Rates come from the 44 official filings published by SIX Exchange Regulation. A filing is only required when a threshold is crossed (3, 5, 10, 15, 20, 25, 33⅓, 50, 66⅔%): the actual position may have changed since.

Estimated value = shares held per the latest filing × latest CHF closing price. It is an indicative order of magnitude: the position may have changed without a new threshold being crossed, and holdings without a share count or a CHF price are not valued. Each company's mini-chart traces the successive declared rates.

This profile shows only what the declarant published. No external data is added to it.

Group structure

Shareholding disclosures are often filed jointly by several entities of the same group. The registry links them together: "Controls" lists the group entities declared alongside this shareholder, "Controlled by" the head entities. The figure is the number of joint disclosures, followed by the date of the most recent one.

Show group structure1 controls

Controls

Group entities linked to this shareholder in joint disclosures.

This mapping reflects observed disclosures; it does not necessarily indicate permanent legal control.

Disclosure behaviour

Upward and downward threshold crossings show direction, without measuring daily trades below legal thresholds.

90 days · Upward crossings

1

visible history: 10

90 days · Downward crossings

2

visible history: 34

First disclosure: 19.10.2012Last disclosure: 03.11.2026

Nature of disclosed positions

Derivatives, sale positions or lending may indicate a more complex strategy than a long equity holding.

Equity holdings
44
Rights / derivatives
27
Sale positions
929

Latest shareholding disclosures

Show 37 older disclosures
PurchaseShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

32.45%Voting rights acquired01.11.2025
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

36.103%Voting rights sold23.10.2025
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

35.741%Voting rights sold25.06.2025
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

49.87%Voting rights sold19.12.2023
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

52.18%Voting rights sold05.12.2023
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

64.39%Voting rights sold10.11.2023
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

67.55%Voting rights sold28.10.2023
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

71.99%Voting rights sold21.06.2023
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

74.96%Voting rights sold25.04.2023
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

74.96%Voting rights sold12.04.2023
PurchaseShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

33.19%Voting rights acquired23.12.2022
PurchaseShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

40.6%Voting rights acquired19.11.2022
PurchaseShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

45.76%Voting rights acquired05.11.2022
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

57.15%Voting rights sold03.11.2022
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

83.87%Voting rights sold12.10.2022
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

75.56%Voting rights sold29.09.2022
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

81.62%Voting rights sold10.08.2022
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

81.68%Voting rights sold30.07.2022
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

42.62%Voting rights sold29.07.2022
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

46.29%Voting rights sold22.07.2022
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

51%Voting rights sold21.04.2022
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

45.33%Voting rights sold09.02.2022
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

60.06%Voting rights sold11.01.2022
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

60.11%Voting rights sold24.12.2021
PurchaseShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

30.99%Voting rights acquired30.04.2021
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

32.79%Voting rights sold12.03.2021
Below thresholdShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Group of shareholders

3%Below threshold12.03.2021
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

32.79%Voting rights sold16.01.2021
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

60.68%Voting rights sold16.01.2021
PurchaseShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Group of shareholders

19.73%Voting rights acquired16.01.2021
PurchaseShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Group of shareholders

16.33%Voting rights acquired16.01.2021
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

35.93%Voting rights sold24.05.2019
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

40.47%Voting rights sold08.06.2018
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

31.84%Voting rights sold14.04.2018
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

71.27%Voting rights sold03.03.2018
PurchaseShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

14.61%Voting rights acquired14.06.2017
SaleShareholdings

Addex Therapeutics Ltd

ADDEX THERAPEUTICS LTD · Single shareholder

12.64%Voting rights sold07.03.2017

insider24.ch

Follow ADDEX THERAPEUTICS LTD’s disclosures

Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open

Management purchases in this portfolio

Loading activity…

    These figures aggregate public disclosures. They are not investment advice.

    Common questions

    Which Swiss companies are in ADDEX THERAPEUTICS LTD’s disclosed portfolio?

    Addex Therapeutics Ltd.

    What is ADDEX THERAPEUTICS LTD’s latest disclosure?

    The latest available disclosure was published on 03.11.2026 and concerns Addex Therapeutics Ltd. Threshold disclosures do not describe every purchase or sale.

    Explore further

    Recent insider purchases

    What are insiders doing at companies disclosed by this shareholder?

    All purchases this week

    Insider barometer

    Compare insider purchases and sales across the Swiss stock exchange over 30 days.

    View the Swiss barometer

    These signals are not investment advice.